2-(2-Cyclobutyl-7-fluoro-1H-1,3-benzodiazol-1-yl)acetic acid, 1g

1-Amino-1H-pyrrole-2-carbonitrile hydrochloride, 95.0%, 250mg

1-(oxetan-3-ylmethyl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 500mg

6-Bromo-2-tetralone, 97.0%, 500g

3-Cyano-benzimidic acid methyl ester, 95.0%, 10g

Methyl 5-cyclopropyl-1H-pyrazole-4-carboxylate, 95.0%, 25g

[2-methyl-1-(2-pyridinyl)propyl]amine, 95.0%, 250mg

Ethyl 3-Ethoxy-3-iminopropanoate Hydrochloride>95.0%(HPLC)(T)5g

(5-Phenylisoxazol-3-yl)methanol, 95.0%, 5g

GC capillary column ROTI®Cap-1, 60 m, 0.32 mm, 3.00 µm, 1 Piece(s)

(R)-3-((tert-butoxycarbonyl)amino)-3-cyclopropylpropanoic acid, 97%, 250mg

(4-Chloro-5-methyl-pyrimidin-2-yl)-cyclopropyl-amine, 95.0%, 1g

2-(2-Methoxy-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g